In this issue of GOLD, we look back at the leading news stories from the past few months in the pharmaceutical industry, covering the latest COVID-19 developments, the most prominent drug approvals, and the standout mergers and acquisitions.
29 June
Com-Cov study investigating COVID-19 vaccine combinations delivers positive results
01 July
Moderna hires Global CEO of Ogilvy, Kate Cronin, to be their first Chief Brand Officer
07 July
Biohaven disrupts migraine market with drug Nurtec as sales exceed estimates by 112%
13 July
Sanofi signs up to be a sponsor of Paris 2024 Olympic games for $94 million
21 July
AstraZeneca completes buyout of Alexion for $39 billion
26 July
BioNTech announces plans to develop a mRNA malaria vaccine
29 July
FDA approves first interchangeable biosimilar insulin product for diabetes
30 July
FDA grants Regeneron’s REGEN-COV emergency use authorisation
03 August
Sanofi buys Translate Bio for approximately $3.2 billion
05 August
Bayer acquires Vividion Therapeutics for up to $2 billion
13 August
FDA approves Jazz Pharmaceutical’s Xywav, the first treatment for idiopathic hypersomnia
16 August
FDA approves use of third dose of Moderna’s vaccine